Jinyang to patent leukemia therapy in U. S.

Jinyang Pharm. Inc. is under development of an anti-leukemia drug research in association with Seoul Samsung hospital, and announced on Sept. 30 that the elimination process of ascorbate in the plasma of leukemia patients was filed to the United States in Oct. 2002 and received its final registration approval from the U. S. Patent office on Sept. 29.

The company said that the new therapy th...